CENTRAL TRUST Co - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
CENTRAL TRUST Co ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,523
+25.0%
354
+18.0%
0.00%
Q2 2023$10,821
-5.6%
3000.0%0.00%
Q1 2023$11,457
-32.9%
3000.0%0.00%
-100.0%
Q4 2022$17,070
+42.2%
3000.0%0.00%
Q3 2022$12,000
-14.3%
300
-7.1%
0.00%
Q2 2022$14,000
+7.7%
3230.0%0.00%
Q1 2022$13,000
+8.3%
323
+7.7%
0.00%
Q4 2021$12,0000.0%3000.0%0.00%
Q3 2021$12,000
-14.3%
3000.0%0.00%
-100.0%
Q2 2021$14,0003000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders